Research Triangle Park, NC (PRWEB) May 23, 2014
Dr. Michael J. Klepper, global expert, author, and consultant in drug safety and pharmacovigilance for 30 years, will conduct two new special seminars for those involved with clinical drug development and postmarketing safety surveillance. These seminars will delve into details and answer specific questions regarding drug safety that are often overlooked by other seminars.
Drug Safety Navigator LLC Founder & President, Dr. Mike Klepper, frequently says, “The proper training and transference of pharmacovigilance knowledge should be the primary goals for all of us with years of on-the-job training and experience. As a medical student, I learned the old axiom – see one, do one, teach one and I feel it is my responsibility to share my knowledge with others.”
The first opportunity to see Dr. Klepper will be at the 17th Annual FDA-OCRA Educational Conference held in San Diego on June 5th, 2014. He will take part in the Clinical Trials breakout session entitled: “Risk Management: Postmarketing Requirements and Strategies”. Dr. Klepper will address the major postmarketing legislation in the US and European Union and discuss the challenges to Biopharmaceutical companies in dealing with the differences between these two regions. This information is important for strategic planning in developing and maintaining a global Pharmacovigilance system with its inherent costs and significant impact on resources. For more information please visit the FDA-OCRA website - http://sabpa.org/html/2014/06/the-17th-annual-fda-ocra-educational-conference-integrated-regulatory-pathways-in-a-global-market/.
The second opportunity will be at the Drug Information Association (DIA) 50th Annual meeting to be held in San Diego, CA, June 15 through June 19, 2014. Dr. Klepper will discuss the challenges and the approaches to take to maximize signal detection during clinical development. This information should help guide individuals in developing a systematic approach and the necessary skills to becoming the best detectives in identifying safety signals during medical product development. Please check their schedule for more information on when his session will take place.
For more information, visit Drug Safety Navigator’s website or contact us directly at 919-371-0610.
About Drug Safety Navigator LLC:
Drug Safety Navigator LLC (DSN) provides highly experienced global drug safety experts for Medical Writing & Consulting, Benefit-Risk assessments, & Safety Signal Detection for our various pharmaceutical and biotech clients. When it comes to patient safety, DSN helps navigate through the murky waters of drug and medical product development. Primarily based in North Carolina, DSN has partners around the world to support our clients and our mission. Our logo says it all: Patient Safety is our True North. To learn more about Drug Safety Navigator LLC, please visit our company website at http://www.drugsafetynavigator.com, follow us on Twitter @DrugSafetyNavig, or call 919-371-0610.
Vice President & Co-Founder
Drug Safety Navigator